Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: MAPP: Imagery-focused Therapy for Bipolar Disorder [NA]
This record notes the completion of the MAPP trial evaluating imagery-focused therapy for bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2015-09-29Clinical Trial Update: Supported Employment: Motivational Enhancement for Entry and Outcome [Phase 2]
Phase 2 clinical trial evaluating a motivational enhancement intervention to support entry into employment and employment outcomes for indiv…
-
FDA approval · 2015-09-23FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote Sprinkles (divalproex sodium) from AbbVie, adding the sprinkle formulation to the produ…
-
FDA approval · 2015-09-23FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote (divalproex sodium) submitted by AbbVie Inc.
-
FDA approval · 2015-09-23FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for divalproex sodium from Aurobindo Pharma Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-09-17FDA Approved: VRAYLAR — Original Application (Allergan, Inc.)
The FDA approved VRAYLAR (cariprazine) under the original application NDA204370 for the treatment of schizophrenia and manic or mixed episod…
-
CLINICAL_TRIALS research · 2015-09-15Clinical Trial Update: Jump Step - A Participatory Approach to Physical Activity & Mental Wellness [NA]
An update on a university-led trial (Jump Step) examining physical activity and mental wellness for individuals with major depressive disord…
-
CLINICAL_TRIALS research · 2015-09-10Clinical Trial Update: Internet-Based Interventions for Bipolar Disorder [NA]
This entry notes a clinical trial evaluating internet-based interventions for bipolar disorder, sponsored by the VA Palo Alto Health Care Sy…
-
FDA approval · 2015-09-04FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for quetiapine fumarate from Hikma Pharmaceuticals USA, indicating approval of changes to the pr…
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Auditory Brainstem Response as a Diagnostic Tool in Schizophrenia and Bipolar Disorder
A completed clinical trial evaluated auditory brainstem response as a diagnostic tool for schizophrenia and bipolar disorder.
-
FDA label_change · 2015-08-28FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis, resulting in labeling changes.
-
FDA approval · 2015-08-27FDA Approved: RISPERIDONE — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for risperidone from Ajanta Pharma USA Inc., indicating an approved regulatory action for this p…
-
FDA approval · 2015-08-21FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for quetiapine fumarate from Aurobindo Pharma Limited, providing a generic version of the antips…
-
FDA approval · 2015-08-20FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone mesylate) submitted by Viatris Specialty LLC to update the approved product.
-
FDA approval · 2015-08-20FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) from Viatris Specialty LLC.
-
FDA approval · 2015-08-14FDA Approved: ARIPIPRAZOLE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's original ANDA for aripiprazole (ARIPIPRAZOLE), enabling the marketing of a generic version of this antipsychotic.
-
FDA approval · 2015-08-12FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
FDA approved a supplemental application for chlorpromazine hydrochloride from Saptalis Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: Assessing the Impact of Self-directed Care, Within a Medicaid-funded Environment,on Participation and Community Living [NA]
Completed clinical trial update evaluating the impact of self-directed care in a Medicaid-funded environment on participation and community …
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Nonconvulsive Electrotherapy: a Proof-of-concept Trial [Phase 1]
Phase 1 proof-of-concept trial of nonconvulsive electrotherapy for depressive and bipolar disorders; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Lamotrigine Monotherapy in Pediatric Bipolar Disorder [Phase 2]
Phase 2 trial assessing lamotrigine as monotherapy for pediatric bipolar disorder; results completed and posted in 2015.
-
FDA approval · 2015-07-27FDA Approved: LITHIUM CARBONATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Rising Pharma Holdings, Inc.'s generic lithium carbonate under an original Abbreviated New Drug Application (ANDA) for use as a…
-
FDA approval · 2015-07-23FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine) from Eli Lilly, adding the intramuscular formulation to the p…
-
EMA withdrawal · 2015-07-20EMA Application withdrawn: Aripiprazole Mylan (aripiprazole) — Generics (UK) Limited
The EMA report indicates withdrawal of the aripiprazole generic application from Generics (UK) Limited for schizophrenia and bipolar disorde…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Liothyronine (T3) for Bipolar Depression [Phase 3]
Phase 3 trial evaluating Liothyronine (T3) for bipolar depression has completed with results posted in 2015. The sponsor is Northwell Health…
-
CLINICAL_TRIALS research · 2015-06-24Clinical Trial Update: The Effect of N- Acetylcysteine on Inflammatory and Oxidative Stress Biomarkers [NA]
This clinical trial investigates the effect of N-acetylcysteine on inflammatory and oxidative stress biomarkers in individuals with bipolar …